Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.79 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.74 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.74 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.57 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | FLT3 | P36888 | 1/20 | 0.50 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16225849 | 0.88 | PTGS1 (0.72) | XDHPTGS1PTGS2HIF1AEPAS1 | |
| Rubrofusarin B SCHEMBL16227248 | 0.88 | XDH (1.00) | XDHPTGS1PTGS2HIF1AEPAS1 | |
| Rubrofusarin B SCHEMBL29779134 | 0.88 | XDH (1.00) | XDHPTGS1PTGS2HIF1AEPAS1 | |
| SCHEMBL1673012 | 0.86 | PTGS1 (0.62) | XDHPTGS1PTGS2HIF1AEPAS1 | |
| Eugenin SCHEMBL1860860 | 0.86 | PTGS1 (1.00) | XDHPTGS1PTGS2HIF1AMAPT | |
| Eugenin SCHEMBL29373728 | 0.86 | PTGS1 (1.00) | XDHPTGS1PTGS2HIF1AMAPT | |
| SCHEMBL15060666 | 0.81 | XDH (0.79) | XDHPTGS1PTGS2HIF1AEPAS1 | |
| SCHEMBL31383372 | 0.81 | ANTXR2 (0.59) | XDHPTGS1PTGS2HIF1AEPAS1 | |
| SCHEMBL16226550 | 0.78 | XDH (0.70) | XDHPTGS1PTGS2HIF1AEPAS1 | |
| SCHEMBL8860537 | 0.77 | PTGS1 (0.64) | XDHPTGS1PTGS2HIF1AEPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116715674-A | Method for extracting various monomer compounds with anti-inflammatory activity from radix Berchemiae Giraldianae and application thereof | 广西国际壮医医院 | 2023-09-08 | — | — | CN | claimed |
| US-20230183705-A1 | PRODUCTS FOR SUPPRESSING OR REDUCING THE EXPRESSION OR ACTIVITY OF A SNORNA AND USES THEREOF IN THE TREATMENT OF CANCER | NINOVAX (FR) | 2023-06-15 | — | — | US | claimed |
| EP-4114944-A1 | PRODUCTS FOR SUPPRESSING OR REDUCING THE EXPRESSION OR ACTIVITY OF A SNORNA AND USES THEREOF IN THE TREATMENT OF CANCER | NINOVAX (FR) | 2023-01-11 | — | — | EP | claimed |
| WO-2021175966-A1 | PRODUCTS FOR SUPPRESSING OR REDUCING THE EXPRESSION OR ACTIVITY OF A SNORNA AND USES THEREOF IN THE TREATMENT OF CANCER | NINOVAX (FR) | 2021-09-10 | — | — | WO | claimed |
| CN-112546060-B | Traditional Chinese medicine monomer composition for reducing blood fat, preparation and application | 北京中医药大学 | 2021-08-31 | — | — | CN | claimed |
| CN-112546060-A | Traditional Chinese medicine monomer composition for reducing blood fat, preparation and application | 北京中医药大学 | 2021-03-26 | — | — | CN | claimed |
| WO-2019162974-A1 | METHOD TO DIAGNOSE CANCER PROGRESSION BASED ON PROKARYOTIC BIOMARKERS AND MOLECULES FOR USE IN THE TREATMENT OF CANCER PROGRESSION | ULISSE BIOMED S.R.L. (IT) | 2019-08-29 | — | — | WO | claimed |
| EP-2488152-B1 | COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION | OREAL (FR) | 2018-04-04 | — | — | EP | claimed |
| CN-107200760-A | A kind of preparation method of high-purity rubrofusarin -6-O- β-O-gentibioside | 长沙博海生物科技有限公司 | 2017-09-26 | — | — | CN | claimed |
| CN-103073604-B | The method that rubrofusarin O-gentibioside and different rubrofusarin O-gentibioside transform mutually | LIAONING UNIVERSITY OF TCM (CN) | 2015-10-28 | — | — | CN | claimed |
| CN-102093449-B | Method for separating and preparing fusarubin gentiobioside from cassia seeds | LIU BIN | 2014-01-22 | — | — | CN | claimed |
| US-8551189-B2 | Composition comprising at least one 1,8-dihydroxynaphthalene derivative and at least one basifying agent different from aqueous ammonia, process for dyeing keratin fibres using the composition | L'OREAL (FR) | 2013-10-08 | — | — | US | claimed |
| CN-103073604-A | Method for mutual transformation of rubrofusarin gentiobioside and heterogeneous rubrofusarin gentiobioside | UNIV LIAONING TRAD CHINESE MED | 2013-05-01 | — | — | CN | claimed |
| EP-2488152-A2 | COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION | L'Oréal (FR) | 2012-08-22 | — | — | EP | claimed |
| WO-2011045403-A2 | COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION | L'OREAL (FR) | 2011-04-21 | — | — | WO | claimed |
| US-20080182803-A1 | extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders | SUNTORY LIMITED | 2008-07-31 | — | — | US | claimed |
| WO-2006060839-A2 | METHOD FOR IDENTIFYING PPT INHIBITORS | UNIVERSITÄT FÜR BODENKULTUR WIEN (AT) | 2006-06-15 | — | — | WO | claimed |
| US-20060110474-A1 | Rubrofusarin glycoside-containing composition | SUNTORY LIMITED (JP) | 2006-05-25 | — | — | US | claimed |
| EP-1552838-A1 | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | SUNTORY LIMITED (JP) | 2005-07-13 | — | — | EP | claimed |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250169516-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-05-29 | — | — | US | disclosed |
| WO-2025059358-A1 | FUNGAL STRAINS HAVING REDUCED OR ELIMINATED MYCOTOXIN, ETHANOL, AND/OR PIGMENT PRODUCTION CAPACITY | THE FYNDER GROUP, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| US-12239142-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-03-04 | — | — | US | disclosed |
| CN-119405576-A | Whitening composition containing ginseng and pomegranate and application thereof | 北京青颜博识健康管理有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-112996799-B | Composition for neuroprotection comprising naphthopyranone derivative derived from cassia bud | 韩国科学技术研究院 | 2025-02-07 | — | — | CN | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| US-20240268402-A1 | Methods, Devices and Compositions for Preserving Human Milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2024-08-15 | — | — | US | disclosed |
| CN-118161568-A | Composition and ointment formula for soothing liver and relieving depression as well as preparation method and application of composition and ointment formula | 北京泰开尔营养科技发展有限责任公司 | 2024-06-11 | — | — | CN | disclosed |
| US-20240076654-A1 | AUTOMATED METHODS FOR SCALABLE, PARALLELIZED ENZYMATIC BIOPOLYMER SYNTHESIS AND MODIFICATION USING MICROFLUIDIC DEVICES | U.S. DEPARTMENT OF ENERGY | 2024-03-07 | — | — | US | disclosed |
| US-11851651-B2 | Automated methods for scalable, parallelized enzymatic biopolymer synthesis and modification using microfluidic devices | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-12-26 | — | — | US | disclosed |
| US-20230292766-A1 | Biocontrol of Fusarium by Endophytic Fungi | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2023-09-21 | — | — | US | disclosed |
| CN-116715674-A | Method for extracting various monomer compounds with anti-inflammatory activity from radix Berchemiae Giraldianae and application thereof | 广西国际壮医医院 | 2023-09-08 | — | — | CN | disclosed |
| US-20230183705-A1 | PRODUCTS FOR SUPPRESSING OR REDUCING THE EXPRESSION OR ACTIVITY OF A SNORNA AND USES THEREOF IN THE TREATMENT OF CANCER | NINOVAX (FR) | 2023-06-15 | — | — | US | disclosed |
| EP-4114944-A1 | PRODUCTS FOR SUPPRESSING OR REDUCING THE EXPRESSION OR ACTIVITY OF A SNORNA AND USES THEREOF IN THE TREATMENT OF CANCER | NINOVAX (FR) | 2023-01-11 | — | — | EP | disclosed |
| CN-109568538-B | Composition for relieving hangover comprising Silybum marianum, Curcuma longa, Glycyrrhiza glabra and Cassia tora seed | 海维尔D&H有限公司 | 2022-02-25 | — | — | CN | disclosed |
| WO-2021175966-A1 | PRODUCTS FOR SUPPRESSING OR REDUCING THE EXPRESSION OR ACTIVITY OF A SNORNA AND USES THEREOF IN THE TREATMENT OF CANCER | NINOVAX (FR) | 2021-09-10 | — | — | WO | disclosed |
| CN-112546060-B | Traditional Chinese medicine monomer composition for reducing blood fat, preparation and application | 北京中医药大学 | 2021-08-31 | — | — | CN | disclosed |
| CN-112546060-B | Traditional Chinese medicine monomer composition for reducing blood fat, preparation and application | 北京中医药大学 | 2021-08-31 | — | — | CN | disclosed |
| CN-112996799-A | Composition for protecting nerve cells comprising naphthopyrone derivative derived from sprout of cassia seed | 韩国科学技术研究院 | 2021-06-18 | — | — | CN | disclosed |
| CN-112457285-B | Preparation method of naphthopyrone enrichment substance | 武汉森澜生物科技有限公司 | 2021-06-15 | — | — | CN | disclosed |
| CN-112546060-A | Traditional Chinese medicine monomer composition for reducing blood fat, preparation and application | 北京中医药大学 | 2021-03-26 | — | — | CN | disclosed |
| CN-112546060-A | Traditional Chinese medicine monomer composition for reducing blood fat, preparation and application | 北京中医药大学 | 2021-03-26 | — | — | CN | disclosed |
| CN-112457285-A | Preparation method of naphthopyrone enrichment substance | 武汉森澜生物科技有限公司 | 2021-03-09 | — | — | CN | disclosed |
| CN-111454993-B | Semen cassiae fermentation product and application thereof | 武汉森澜生物科技有限公司 | 2021-01-15 | — | — | CN | disclosed |
| CN-111973717-A | A composition containing fructus Perillae and semen Cassiae for reducing weight, and its preparation method | 西安皇家医疗保健品有限公司 | 2020-11-24 | — | — | CN | disclosed |
| CN-111228325-A | Method for extracting whole components of semen cassiae | 广州泽力医药科技有限公司 | 2020-06-05 | — | — | CN | disclosed |
| CN-111228325-A | Method for extracting whole components of semen cassiae | 广州泽力医药科技有限公司 | 2020-06-05 | — | — | CN | disclosed |
| EP-3641929-A2 | AUTOMATED METHODS FOR SCALABLE, PARALLELIZED ENZYMATIC BIOPOLYMER SYNTHESIS AND MODIFICATION USING MICROFLUIDIC DEVICES | Massachusetts Institute Of Technology (US) | 2020-04-29 | — | — | EP | disclosed |
| WO-2020017864-A1 | PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR FROM ANTARCTIC MARINE-DERIVED ASPERGILLUS SP. SF-5929 | 한국해양과학기술원 | 2020-01-23 | — | — | WO | disclosed |
| CN-105744983-B | Device and method for sustained release of therapeutic agents of low water solubility in solubilizing agents | 纳米医学系统公司 | 2019-12-27 | — | — | CN | disclosed |
| CN-110463800-A | A kind of four seasons tea | GANSU MINGUI TRADITIONAL CHINESE MEDICINE MATERIALS TECH CO LTD | 2019-11-19 | — | — | CN | disclosed |
| CN-110447741-A | A kind of Qi yellow tea | GANSU MINGUI TRADITIONAL CHINESE MEDICINE MATERIALS TECH CO LTD | 2019-11-15 | — | — | CN | disclosed |
| WO-2019162974-A1 | METHOD TO DIAGNOSE CANCER PROGRESSION BASED ON PROKARYOTIC BIOMARKERS AND MOLECULES FOR USE IN THE TREATMENT OF CANCER PROGRESSION | ULISSE BIOMED S.R.L. (IT) | 2019-08-29 | — | — | WO | disclosed |
| CN-109793241-A | A kind of functional food and preparation method thereof adjusting blood pressure using soybean as primary raw material | 因皇生物科技有限公司 | 2019-05-24 | — | — | CN | disclosed |
| CN-109717271-A | A kind of lotus profit tea plant alternative tea and manufacture craft | 上海寿叶生物科技有限公司 | 2019-05-07 | — | — | CN | disclosed |
| CN-109568538-A | Resolution composition of being still drank after a night comprising milk thistle, turmeric, Radix Glycyrrhizae and cassia seed | 海维尔D&H有限公司 | 2019-04-05 | — | — | CN | disclosed |
| US-20180362969-A1 | AUTOMATED METHODS FOR SCALABLE, PARALLELIZED ENZYMATIC BIOPOLYMER SYNTHESIS AND MODIFICATION USING MICROFLUIDIC DEVICES | UNITED STATES DEPARTMENT OF ENERGY | 2018-12-20 | — | — | US | disclosed |
| CN-108743925-A | A kind of Chinese medicine preparation eye-care medicament and preparation method thereof | 江苏百剑药业科技有限公司 | 2018-11-06 | — | — | CN | disclosed |
| CN-108404560-A | Remove the plant composition of PM2.5 | 国润生物科技（深圳）有限公司 | 2018-08-17 | — | — | CN | disclosed |
| CN-108261862-A | Plant type haze removes composition | 国润生物科技（深圳）有限公司 | 2018-07-10 | — | — | CN | disclosed |
| CN-104771601-B | A kind of combination agent for improving blood viscosity and hematoblastic aggregation | 张坤镛 | 2018-06-19 | — | — | CN | disclosed |
| EP-2488152-B1 | COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION | OREAL (FR) | 2018-04-04 | — | — | EP | disclosed |
| EP-2488152-B1 | COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION | OREAL (FR) | 2018-04-04 | — | — | EP | disclosed |
| CN-104983836-B | A kind of method that active component is extracted in the bulk drug peaceful from compound blood fat | 天津中医药大学 | 2018-03-30 | — | — | CN | disclosed |
| CN-107468818-A | A kind of compound Chinese medicinal preparation of relieving eye strain | 深圳市颐晋生命科学有限公司 | 2017-12-15 | — | — | CN | disclosed |
| CN-107441387-A | A kind of Chinese medicinal formulae for being used to treat damp-heat constitution acne | 王停 | 2017-12-08 | — | — | CN | disclosed |
| CN-107397967-A | Can effectively solve the air purifying preparation of parking facility air pollutants | 王婧宁 | 2017-11-28 | — | — | CN | disclosed |
| US-20170298209-A1 | USE OF A QUINONE COMPOUND IN BUILDING MATERIALS | ARKION LIFE SCIENCES, LLC (US) | 2017-10-19 | — | — | US | disclosed |
| CN-107200760-A | A kind of preparation method of high-purity rubrofusarin -6-O- β-O-gentibioside | 长沙博海生物科技有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-107200760-A | A kind of preparation method of high-purity rubrofusarin -6-O- β-O-gentibioside | 长沙博海生物科技有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-106924583-A | A kind of Chinese medicine composition and nourishing face and eliminating toxin healthy care drink based on ancient prescription | 地百乐（深圳）实业发展有限公司 | 2017-07-07 | — | — | CN | disclosed |
| CN-106581142-A | Compound traditional Chinese medicine composition capable of regulating blood fat and purpose thereof | 哈尔滨医科大学 | 2017-04-26 | — | — | CN | disclosed |
| CN-106418540-A | Functional beverage capable of protecting liver and clearing away toxin and preparation method thereof | 威海恒基伟业信息科技发展有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106173093-A | Preparation method of sweet semen cassiae tea with effects of clearing liver and improving eyesight, and reducing blood sugar and blood fat | 刘翰锦 | 2016-12-07 | — | — | CN | disclosed |
| CN-106176350-A | Bath gel with effect of weight reducing and preparation method thereof | 宋东宁 | 2016-12-07 | — | — | CN | disclosed |
| CN-105999051-A | Drug for assisting surgery in treatment of abdominal wall desmoid fibromatosis | 济南思拓新源医药科技有限公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-105941858-A | Winter carp feed additive | 山东新希望六和集团有限公司 | 2016-09-21 | — | — | CN | disclosed |
| CN-104042524-B | A kind of Chinese medicine preparation eye-care medicament and preparation method thereof | 刘志伟 | 2016-09-07 | — | — | CN | disclosed |
| CN-104041907-B | A kind of liver detoxification drinks and preparation method thereof | 黔西南吉仁堂保健食品有限公司 | 2016-06-29 | — | — | CN | disclosed |
| CN-103721072-B | Improve the medicine pill of sexual impotence, premature ejaculation | ZHENGZHOU KANGJIAN ELECTRONIC PRODUCTS RESEARCH INSTITUTE (CN) | 2016-03-02 | — | — | CN | disclosed |
| CN-103073604-B | The method that rubrofusarin O-gentibioside and different rubrofusarin O-gentibioside transform mutually | LIAONING UNIVERSITY OF TCM (CN) | 2015-10-28 | — | — | CN | disclosed |
| CN-103073604-B | The method that rubrofusarin O-gentibioside and different rubrofusarin O-gentibioside transform mutually | LIAONING UNIVERSITY OF TCM (CN) | 2015-10-28 | — | — | CN | disclosed |
| CN-103073604-B | The method that rubrofusarin O-gentibioside and different rubrofusarin O-gentibioside transform mutually | LIAONING UNIVERSITY OF TCM (CN) | 2015-10-28 | — | — | CN | disclosed |
| WO-2015160043-A1 | CONSTIPATION PREVENTION AND ALLEVIATION AGENT USING CASSIA TORA L. AND PREPARATION METHOD THEREFOR | 해남자연농업영농조합법인 | 2015-10-22 | — | — | WO | disclosed |
| CN-104983836-A | Method for extracting active components from compound blood lipid ning bulk drugs | UNIV TIANJIN TRADITIONAL CHINESE MEDICINE | 2015-10-21 | — | — | CN | disclosed |
| CN-104888016-A | Traditional Chinese medicine preparation for treating conjunctivitis and preparation method of traditional Chinese medicine preparation | WANG FENG | 2015-09-09 | — | — | CN | disclosed |
| US-20150224157-A1 | PROCESS FOR THE PREPARATION OF HERBAL EXTRACT OF CASSIA TORA LEAVES FOR TREATING ANXIETY DISORDERS | COUNCIL SCIENT IND RES (IN) | 2015-08-13 | — | — | US | disclosed |
| US-20150208657-A1 | USE OF QUINONE COMPOUND IN BUILDING MATERIALS | ARKION LIFE SCIENCES, LLC (US) | 2015-07-30 | — | — | US | disclosed |
| CN-104771601-A | Combination agent for improving blood viscosity and platelet aggregation | ZHANG KUNYONG | 2015-07-15 | — | — | CN | disclosed |
| CN-104706972-A | Traditional Chinese medicine preparation capable of promoting blood circulation for removing obstruction in collaterals, for treating radioactive cataract and preparation method | LI JUN | 2015-06-17 | — | — | CN | disclosed |
| CN-104623316-A | Traditional Chinese medicine composition capable of nourishing liver and tonifying kidneys to treat radiation cataract and preparation method of traditional Chinese medicine composition | LI JUN | 2015-05-20 | — | — | CN | disclosed |
| CN-104547779-A | Lipid lowering and meridian unblocking medicament for treating chronic arteriosclerosis and preparation method of medicament | WANG SHIGUO | 2015-04-29 | — | — | CN | disclosed |
| CN-104491025-A | Liver and kidney tonifying traditional Chinese medicine agent for hypertension patients and preparation method thereof | LIU BAOXIANG | 2015-04-08 | — | — | CN | disclosed |
| CN-104287035-A | Method for preparing semen cassiae carbonated beverage | JIANGSU QILIKANG SKIN PHARMACEUTICAL CO LTD | 2015-01-21 | — | — | CN | disclosed |
| CN-104187599-A | Health food with beauty-maintaining fatigue-resisting effects and preparation method thereof | LIANG DING | 2014-12-10 | — | — | CN | disclosed |
| CN-103330257-B | Natural plant beverage and preparation method thereof | SHENZHEN BAILIQI INVEST DEV CO LTD | 2014-09-17 | — | — | CN | disclosed |
| CN-104041907-A | Liver-protecting and detoxicating functional beverage and preparation method thereof | QIANXINAN JIRENTANG HEALTH FOOD CO LTD | 2014-09-17 | — | — | CN | disclosed |
| CN-104042524-A | Chinese herb medicament for eye treatment and preparation method thereof | LIU HONGLI | 2014-09-17 | — | — | CN | disclosed |
| CN-103721072-A | Traditional Chinese medicine pill for improving impotence and premature ejaculation | ZHENGZHOU INST OF KANGJIAN ELECTRONIC PRODUCT | 2014-04-16 | — | — | CN | disclosed |
| CN-103689561-A | Health-preserving health food formula beneficial for reducing lipid and losing weight and preparation method thereof | TIANJIN CHASESUN PHARM CO LTD | 2014-04-02 | — | — | CN | disclosed |
| CN-103598377-A | Blood pressure reduction traditional Chinese medicinal herbal tea and preparation method thereof | LI ZONGYU | 2014-02-26 | — | — | CN | disclosed |
| EP-2411030-B1 | Herbal extract of Casia tora leaves for use in the treatment of anxiety disorders | COUNCIL SCIENT IND RES (IN) | 2014-01-29 | — | — | EP | disclosed |
| US-8637098-B2 | Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea | Nam, Jong Hyun (KR) | 2014-01-28 | — | — | US | disclosed |
| CN-102093449-B | Method for separating and preparing fusarubin gentiobioside from cassia seeds | LIU BIN | 2014-01-22 | — | — | CN | disclosed |
| CN-103478333-A | Healthcare tea with function of reducing blood fat | UNIV HUBEI ARTS & SCIENCE | 2014-01-01 | — | — | CN | disclosed |
| CN-102787055-B | Health wine for body building | HAO ZHENDONG | 2013-12-25 | — | — | CN | disclosed |
| US-8551189-B2 | Composition comprising at least one 1,8-dihydroxynaphthalene derivative and at least one basifying agent different from aqueous ammonia, process for dyeing keratin fibres using the composition | L'OREAL (FR) | 2013-10-08 | — | — | US | disclosed |
| US-8551189-B2 | Composition comprising at least one 1,8-dihydroxynaphthalene derivative and at least one basifying agent different from aqueous ammonia, process for dyeing keratin fibres using the composition | L'OREAL (FR) | 2013-10-08 | — | — | US | disclosed |
| US-8551189-B2 | Composition comprising at least one 1,8-dihydroxynaphthalene derivative and at least one basifying agent different from aqueous ammonia, process for dyeing keratin fibres using the composition | L'OREAL (FR) | 2013-10-08 | — | — | US | disclosed |
| CN-103330257-A | Natural plant beverage and preparation method thereof | SHENZHEN BAILIQI INVEST DEV CO LTD | 2013-10-02 | — | — | CN | disclosed |
| US-20130219633-A1 | COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION | L'OREAL (FR) | 2013-08-29 | — | — | US | disclosed |
| US-20130219633-A1 | COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION | L'OREAL (FR) | 2013-08-29 | — | — | US | disclosed |
| CN-103073604-A | Method for mutual transformation of rubrofusarin gentiobioside and heterogeneous rubrofusarin gentiobioside | UNIV LIAONING TRAD CHINESE MED | 2013-05-01 | — | — | CN | disclosed |
| CN-103073604-A | Method for mutual transformation of rubrofusarin gentiobioside and heterogeneous rubrofusarin gentiobioside | UNIV LIAONING TRAD CHINESE MED | 2013-05-01 | — | — | CN | disclosed |
| CN-103073604-A | Method for mutual transformation of rubrofusarin gentiobioside and heterogeneous rubrofusarin gentiobioside | UNIV LIAONING TRAD CHINESE MED | 2013-05-01 | — | — | CN | disclosed |
| CN-101404898-B | Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea | NAM JONG HYUN | 2013-05-01 | — | — | CN | disclosed |
| CN-102787055-A | Health wine for body building | ZHENDONG HAO | 2012-11-21 | — | — | CN | disclosed |
| WO-2012136782-A1 | METHOD OF DYEING OR MAKING UP KERATIN FIBRES USING A PIGMENT RESULTING FROM A 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE, COMPOSITION CONTAINING THE PIGMENT AND THE PIGMENT | L'OREAL (FR) | 2012-10-11 | — | — | WO | disclosed |
| US-20120219649-A1 | PROCESS FOR THE PREPARATION OF HERBAL EXTRACT OF CASSIA TORA LEAVES FOR TREATING ANXIETY DISORDERS | COUNCIL OF SCIENCE AND INDUSTRIAL RESEARCH (IN) | 2012-08-30 | — | — | US | disclosed |
| EP-2003988-B1 | NATURAL PLANT EXTRACT COMPOSITION FOR PREVENTION AND RECOVERY OF HYPERLIPIDEMIA AND STROKE, NATURAL TEA CONTAINING THE SAME AS ACTIVE INGREDIENT AND METHOD FOR PREPARING THE NATURAL TEA | NAM JONG HYUN (KR) | 2012-06-13 | — | — | EP | disclosed |
| CN-102451613-A | Natural formaldehyde purifying agent and preparation method thereof | CHENGDU SHUNFA DISINFECTANT & WASHING TECH CO LTD | 2012-05-16 | — | — | CN | disclosed |
| CN-102406045-A | Frozen beverage added with semen cassiae and preparation method thereof | INNER MONGOLIA YILI IND GROUP | 2012-04-11 | — | — | CN | disclosed |
| EP-2411030-A1 | Process for the preparation of herbal extract of cassia tora leaves for treating anxiety disorders | Council of Scientific & Industrial Research (IN) | 2012-02-01 | — | — | EP | disclosed |
| CN-101698028-B | Fat-reducing and weight-losing composite and preparation method thereof | QINGWEN SU | 2011-10-26 | — | — | CN | disclosed |
| CN-101243882-B | Health food with function of reducing blood fat and its preparation | BEIJING HUIZHONGMINGJIE BIOTECHNOLOGY CO LTD | 2011-05-04 | — | — | CN | disclosed |
| WO-2011045403-A2 | COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION | L'OREAL (FR) | 2011-04-21 | — | — | WO | disclosed |
| WO-2010109318-A1 | PROCESS FOR THE PREPARATION OF HERBAL EXTRACT OF CASSIA TORA LEAVES FOR TREATING ANXIETY DISORDERS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-09-30 | — | — | WO | disclosed |
| CN-101698028-A | Fat-reducing and weight-losing composite and preparation method thereof | QINGWEN SU | 2010-04-28 | — | — | CN | disclosed |
| CN-101496604-A | Nutrient foodstuffs with function for reducing blood fat and preparation method thereof | BEIJING HUIZHONG MINGJIE BIOLO (CN) | 2009-08-05 | — | — | CN | disclosed |
| US-20090098223-A1 | NATURAL PLANT EXTRACT COMPOSITION FOR PREVENTION AND RECOVERY OF HYPERLIPIDEMIA AND STROKE, NATURAL TEA CONTAINING THE SAME AS ACTIVE INGREDIENT AND METHOD FOR PREPARING THE NATURAL TEA | NAM JONG HYUN | 2009-04-16 | — | — | US | disclosed |
| CN-101404898-A | Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea | HYUN NAM JONG (KR) | 2009-04-08 | — | — | CN | disclosed |
| CN-100448434-C | Liver-benefiting health food made from pure Chinese medicine | BEIJING YAOGU LEGEND PHARMACEU (CN) | 2009-01-07 | — | — | CN | disclosed |
| EP-2003988-A1 | NATURAL PLANT EXTRACT COMPOSITION FOR PREVENTION AND RECOVERY OF HYPERLIPIDEMIA AND STROKE, NATURAL TEA CONTAINING THE SAME AS ACTIVE INGREDIENT AND METHOD FOR PREPARING THE NATURAL TEA | Nam, Jong Hyun (KR) | 2008-12-24 | — | — | EP | disclosed |
| CN-100441110-C | Health article for regulating blood serum HDL-C concentration and treating hyperlipemia | LIU HAILONG (CN) | 2008-12-10 | — | — | CN | disclosed |
| WO-2008100977-A2 | CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS | N.V. ORGANON (NL) | 2008-08-21 | — | — | WO | disclosed |
| CN-101243882-A | Health food with function of reducing blood fat and its preparation | BEIJING HUIZHONGMINGJIE BIOTEC (CN) | 2008-08-20 | — | — | CN | disclosed |
| US-20080182803-A1 | extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders | SUNTORY LIMITED | 2008-07-31 | — | — | US | disclosed |
| US-20080182803-A1 | extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders | SUNTORY LIMITED | 2008-07-31 | — | — | US | disclosed |
| US-20080182803-A1 | extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders | SUNTORY LIMITED | 2008-07-31 | — | — | US | disclosed |
| JP-2008007473-A | CASSIA OBTUSIFOLIA L. OR CASSIA TORA L. SEED EXTRACT | SUNTORY LTD | 2008-01-17 | — | — | JP | disclosed |
| EP-1552838-A4 | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | SUNTORY LTD (JP) | 2007-12-12 | — | — | EP | disclosed |
| WO-2007111401-A1 | NATURAL PLANT EXTRACT COMPOSITION FOR PREVENTION AND RECOVERY OF HYPERLIPIDEMIA AND STROKE, NATURAL TEA CONTAINING THE SAME AS ACTIVE INGREDIENT AND METHOD FOR PREPARING THE NATURAL TEA | NAM JONG HYUN (KR) | 2007-10-04 | — | — | WO | disclosed |
| CN-1973687-A | Health oyster-turtle powder | SHANGHAI AQUATIC UNIV (CN) | 2007-06-06 | — | — | CN | disclosed |
| CN-1883687-A | Liver-benefiting health food made from pure Chinese medicine | BEIJING YAOGU LEGEND PHARMACEU (CN) | 2006-12-27 | — | — | CN | disclosed |
| CN-1883305-A | Method for preparing seasonings by combination of peony natural organic compounds | ZHANG YINGQIANG (CN) | 2006-12-27 | — | — | CN | disclosed |
| WO-2006060839-A2 | METHOD FOR IDENTIFYING PPT INHIBITORS | UNIVERSITÄT FÜR BODENKULTUR WIEN (AT) | 2006-06-15 | — | — | WO | disclosed |
| US-20060110474-A1 | Rubrofusarin glycoside-containing composition | SUNTORY LIMITED (JP) | 2006-05-25 | — | — | US | disclosed |
| US-20060110474-A1 | Rubrofusarin glycoside-containing composition | SUNTORY LIMITED (JP) | 2006-05-25 | — | — | US | disclosed |
| US-20060110474-A1 | Rubrofusarin glycoside-containing composition | SUNTORY LIMITED (JP) | 2006-05-25 | — | — | US | disclosed |
| CN-1745641-A | Vegetative for tified anticancer flour | QUAN YINGBIN (CN) | 2006-03-15 | — | — | CN | disclosed |
| CN-1706279-A | Health article for regulating blood serum HDL-C concentration and treating hyperlipemia | LIU HAILONG (CN) | 2005-12-14 | — | — | CN | disclosed |
| EP-1552838-A1 | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | SUNTORY LIMITED (JP) | 2005-07-13 | — | — | EP | disclosed |
| EP-1552838-A1 | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | SUNTORY LIMITED (JP) | 2005-07-13 | — | — | EP | disclosed |
| EP-1552838-A1 | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | SUNTORY LIMITED (JP) | 2005-07-13 | — | — | EP | disclosed |
| CN-1568797-A | Nutritious preparation and its making method | YIN YUNGUI (CN) | 2005-01-26 | — | — | CN | disclosed |
| CN-1568796-A | Method for making haw nutritious preparation | YIN YUNGUI (CN) | 2005-01-26 | — | — | CN | disclosed |
| JP-2004002231-A | COMPOSITION COMPRISING RUBROFUSARIN GLYCOSIDE | SUNTORY LTD | 2004-01-08 | — | — | JP | disclosed |
| JP-2004002231-A | COMPOSITION COMPRISING RUBROFUSARIN GLYCOSIDE | SUNTORY LTD | 2004-01-08 | — | — | JP | disclosed |
| WO-2003101466-A1 | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | SUNTORY LIMITED (JP) | 2003-12-11 | — | — | WO | disclosed |
| EP-1005267-A4 | PHOTOTHERAPY BASED METHOD FOR TREATING PATHOGENS AND COMPOSITION FOR EFFECTING SAME | DERMATOLAZER TECHNOLOGIES LTD (IL) | 2003-07-09 | — | — | EP | disclosed |
| CN-1111039-C | Chinese patent medicine for preventing and treating cardiovascular and cerebrovascular diseases | ZHAO DERUN (CN) | 2003-06-11 | — | — | CN | disclosed |
| CN-1284347-A | Chinese patent medicine for preventing and treating cardiovascular and cerebrovascular diseases | ZHAO DERUN (CN) | 2001-02-21 | — | — | CN | disclosed |
| US-6090788-A | IRRADIATING THE AREA OF SKIN OR NAIL WITH A LIGHT BEAM HAVING AT LEAST ONE WAVELENGTH ABSORBABLE BY THE PATHOGEN TO DESTRUCT THE FUNGAL PATHOGEN | DERMATOLAZER TECHNOLOGIES LTD. (IL) | 2000-07-18 | — | — | US | disclosed |
| EP-1005267-A1 | PHOTOTHERAPY BASED METHOD FOR TREATING PATHOGENS AND COMPOSITION FOR EFFECTING SAME | Dermatolazer Technologies Ltd. (IL) | 2000-06-07 | — | — | EP | disclosed |
| US-5958417-A | REDUCE SERUM CHOLESTEROL AND TRIGLYCERIDE LEVELS | HSU CHAU-SHIN (US) | 1999-09-28 | — | — | US | disclosed |
| WO-1999004628-A1 | PHOTOTHERAPY BASED METHOD FOR TREATING PATHOGENS AND COMPOSITION FOR EFFECTING SAME | DERMATOLAZER TECHNOLOGIES LTD. (IL) | 1999-02-04 | — | — | WO | disclosed |
| CN-1149481-A | Capsule for enhancing eyesight | GUO LIANGCAI (CN) | 1997-05-14 | — | — | CN | disclosed |
| CN-1087539-A | Health powder with snake soft-shelled turtle | YANG DONGWEN (CN) | 1994-06-08 | — | — | CN | disclosed |
| CN-1087539-A | Health powder with snake soft-shelled turtle | YANG DONGWEN (CN) | 1994-06-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130219633-A1 | COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION | KRT18, DSG1, TUBA8 | XDH 869/4885PTGS1 3787/4885PTGS2 3978/4885 |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | XDH 171/4885PTGS1 4638/4885PTGS2 4537/4885 |
| US-20060110474-A1 | Rubrofusarin glycoside-containing composition | GSTP1, GLS, MGST3 | XDH 1584/4885PTGS1 814/4885PTGS2 901/4885 |
| US-20080182803-A1 | extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders | GSS, GSTP1, GSTM2 | XDH 1013/4885PTGS1 1554/4885PTGS2 1374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.